首页> 外文期刊>The Journal of biological chemistry >Nickel Ions Inhibit Histone Demethylase JMJD1A and DNA Repair Enzyme ABH2 by Replacing the Ferrous Iron in the Catalytic Centers
【24h】

Nickel Ions Inhibit Histone Demethylase JMJD1A and DNA Repair Enzyme ABH2 by Replacing the Ferrous Iron in the Catalytic Centers

机译:镍离子通过在催化中心替代碳铁抑制组蛋白脱甲基酶JMJD1A和DNA修复酶ABH2

获取原文
获取外文期刊封面目录资料

摘要

Iron- and 2-oxoglutarate-dependent dioxygenases are a diverse family of non-heme iron enzymes that catalyze various important oxidations in cells. A key structural motif of these dioxygenases is a facial triad of 2-histidines-1-carboxylate that coordinates the Fe(II) at the catalytic site. Using histone demethylase JMJD1A and DNA repair enzyme ABH2 as examples, we show that this family of dioxygenases is highly sensitive to inhibition by carcinogenic nickel ions. We find that, with iron, the 50% inhibitory concentrations of nickel (IC50 [Ni(II)]) are 25 μm for JMJD1A and 7.5 μm for ABH2. Without iron, JMJD1A is 10 times more sensitive to nickel inhibition with an IC50 [Ni(II)] of 2.5 μm, and approximately one molecule of Ni(II) inhibits one molecule of JMJD1A, suggesting that nickel causes inhibition by replacing the iron. Furthermore, nickel-bound JMJD1A is not reactivated by excessive iron even up to a 2 mm concentration. Using x-ray absorption spectroscopy, we demonstrate that nickel binds to the same site in ABH2 as iron, and replacement of the iron by nickel does not prevent the binding of the cofactor 2-oxoglutarate. Finally, we show that nickel ions target and inhibit JMJD1A in intact cells, and disruption of the iron-binding site decreases binding of nickel ions to ABH2 in intact cells. Together, our results reveal that the members of this dioxygenase family are specific targets for nickel ions in cells. Inhibition of these dioxygenases by nickel is likely to have widespread impacts on cells (e.g. impaired epigenetic programs and DNA repair) and may eventually lead to cancer development.
机译:依赖铁抑制的二恶英酶是一种多样的非血红素碳酸族,催化细胞中的各种重要氧化。这些二恶英酶的关键结构基质是2-组氨酸-1-羧酸盐的面部三合会,其在催化位点处协调Fe(II)。使用组蛋白脱甲基酶JMJD1A和DNA修复酶ABH2作为实施例,我们表明,这种二恶英酶的系列对致癌镍离子的抑制非常敏感。我们发现,用铁,镍(IC50 [Ni(IC50)]的50%抑制浓度为25μm,用于ABH2的JMJD1A和7.5μm。没有铁,JMJD1A对镍抑制敏感的10倍,用2.5μm的IC50 [Ni(II)],大约一个Ni(II)抑制一种JMJD1A分子,表明镍通过更换铁来抑制抑制。此外,镍结合的JMJD1A不会通过过多的铁而重新激活,即使高达2mm浓度也是如此。使用X射线吸收光谱,我们证明镍作为铁的ABH2中的同一部位结合,并且通过镍更换铁不会阻止辅因子2-氧缺乏酸的结合。最后,我们表明镍离子靶向和抑制完整细胞中的JMJD1A,并且铁结​​合位点的破坏降低了完整细胞中镍离子与ABH2的结合。我们的结果表明,该二恶英酶系列的成员是细胞中镍离子的特异性靶标。镍通过镍抑制这些二恶英酶可能对细胞(例如受损的表观遗传程序和DNA修复)具有广泛的影响,并且最终可能导致癌症发育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号